Table 4. Thirty-day major adverse events.
Variables | ID-1 | ID-2 | ID-3 | ID-4 | ID-5 | ID-6 | ID-7 | ID-8 |
Death | ||||||||
In the cath lab | N | N | N | N | N | N | N | N |
After PCI | N | N | N | N | N | N | N | N |
Reinfarction | N | N | N | N | N | N | N | N |
Stroke | N | N | N | N | N | N | N | N |
Target lesion revascularization | N | N | N | N | N | N | N | N |
Any major adverse event | N | N | N | N | N | N | N | N |
Left ventricular failure | N | N | N | N | N | N | N | N |
N: no; PCI: percutaneous coronary intervention.